Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05763043 · ClinicalTrials.gov registry record · Early Phase 1
Monoferric for Prenatal Iron Deficiency
A Early Phase 1 study of Obstetric Labor Complications, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05763043 is a Early Phase 1 study of Obstetric Labor Complications that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 80 participants, below the 91-participant average among 3 other Obstetric Labor Complications trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05763043, a Early Phase 1 study of Obstetric Labor Complications, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
Conditions Studied
Interventions
- DRUG Ferric derisomaltose
Study Locations (1)
Oregon
- Oregon Health & Science Univerity - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2028-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05763043
The ClinicalTrials.gov registry entry for NCT05763043 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 3 other Obstetric Labor Complications trials with a reported enrollment target (12% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obstetric Labor Complications appearing as the primary indexed condition, and to 1 intervention - of which Ferric derisomaltose is the first listed.
NCT05763043 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT05763043 about?
NCT05763043 is a clinical study titled "Monoferric for Prenatal Iron Deficiency". A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
What is the current status of trial NCT05763043?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2024-01-18. Estimated completion is 2028-10.
What conditions does trial NCT05763043 study?
This clinical trial studies the following conditions: Obstetric Labor Complications.
What interventions are being tested in trial NCT05763043?
The interventions under investigation include: Ferric derisomaltose (DRUG).
Who is sponsoring clinical trial NCT05763043?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05763043 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstetric Labor Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.